Common Contracts

16 similar Security Agreement contracts by Cyabra, Inc., Intelligent Bio Solutions Inc., Autonomix Medical, Inc., others

SERIES N-2 COMMON STOCK PURCHASE WARRANT intelligent bio solutions INC.
Security Agreement • September 2nd, 2026 • Intelligent Bio Solutions Inc. • Surgical & medical instruments & apparatus • New York

THIS SERIES N-2 COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [______], or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Shareholder Approval Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five year anniversary following the date a registration statement registering the resale of all Warrant Shares issuable upon exercise of the Warrants is declared effective by the Commission (the “Termination Date”), but not thereafter, to subscribe for and purchase from Intelligent Bio Solutions Inc., a Delaware corporation (the “Company”), up to [_____] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SERIES N-1 COMMON STOCK PURCHASE WARRANT intelligent bio solutions INC.
Security Agreement • September 2nd, 2026 • Intelligent Bio Solutions Inc. • Surgical & medical instruments & apparatus • New York

THIS SERIES N-1 COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [______], or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five year anniversary following the date a registration statement registering the resale of all Warrant Shares issuable upon exercise of the Warrants is declared effective by the Commission (the “Termination Date”), but not thereafter, to subscribe for and purchase from Intelligent Bio Solutions Inc., a Delaware corporation (the “Company”), up to [_____] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SERIES M PREFUNDED COMMON STOCK PURCHASE WARRANT intelligent bio solutions INC.
Security Agreement • September 2nd, 2026 • Intelligent Bio Solutions Inc. • Surgical & medical instruments & apparatus • New York

THIS SERIES M PREFUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [______], or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”), but not thereafter, to subscribe for and purchase from Intelligent Bio Solutions Inc., a Delaware corporation (the “Company”), up to [_____] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SERIES E-1 COMMON STOCK PURCHASE WARRANT
Security Agreement • August 26th, 2026 • Autonomix Medical, Inc. • Surgical & medical instruments & apparatus

THIS SERIES E-1 COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, __________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Autonomix Medical, Inc., a Delaware corporation (the “Company”), up to ___________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SERIES E-2 COMMON STOCK PURCHASE WARRANT AUTONOMIX MEDICAL, INC.
Security Agreement • August 26th, 2026 • Autonomix Medical, Inc. • Surgical & medical instruments & apparatus

THIS SERIES E-2 COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Autonomix Medical, Inc., a Delaware corporation (the “Company”), up to ___________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON STOCK PURCHASE WARRANT NEXALIN TECHNOLOGY, INC.
Security Agreement • August 20th, 2026 • Nexalin Technology, Inc. • Electromedical & electrotherapeutic apparatus

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Alumni Capital LP or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time or times on or after the date hereof (the “Initial Exercise Date”)and on or prior to 5:00 p.m. (New York City time) on the one-year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Nexalin Technology, Inc., a Delaware corporation (the “Company”), up to 1,209,677 shares of common stock, par value $0.001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

PRE-FUNDED COMMON STOCK PURCHASE WARRANT CYPHERPUNK TECHNOLOGIES INC.
Security Agreement • August 18th, 2026 • Cypherpunk Technologies Inc. • Pharmaceutical preparations

THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Winklevoss Treasury Investments, LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”), to subscribe for and purchase from Cypherpunk Technologies Inc., a Delaware corporation (the “Company”), up to 43,290,042 shares of common stock, par value $0.001 per share (the “Common Stock” and such Common Stock underlying this Warrant, subject to adjustment hereunder, the “Warrant Shares”) of the Company. The purchase price of one share of Common Stock underlying this Warrant shall be equal to the Exercise Price set forth in Section 2(b) below.

PRE-FUNDED COMMON STOCK PURCHASE WARRANT CHANGE AGENTS CORPORATION
Security Agreement • August 18th, 2026 • Change Agents Corporation. • Services-computer programming services

THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________, a ______________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after August 14, 2026 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York, NY time) on a date which is five years from the Original Issuance Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from CHANGE AGENTS CORPORATION, a Delaware corporation (the “Company”), up to [One Million (1,000,000)] shares of Common Stock (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

PRE-FUNDED COMMON STOCK PURCHASE WARRANT DERMATA THERAPEUTICS, INC.
Security Agreement • August 17th, 2026 • Dermata Therapeutics, Inc. • Pharmaceutical preparations • New York

THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”), to subscribe for and purchase from Dermata Therapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SERIES [E/F] COMMON STOCK PURCHASE WARRANT DERMATA THERAPEUTICS, INC.
Security Agreement • August 17th, 2026 • Dermata Therapeutics, Inc. • Pharmaceutical preparations • New York

THIS SERIES [E/F] COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the [five (5) year]1/[twenty-four (24) month]2 anniversary of the Initial Exercise Date, provided that, if such date is not a Trading Day, the date that is the immediately following Trading Day (the “Termination Date”), but not thereafter, to subscribe for and purchase from Dermata Therapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

PRE-FUNDED COMMON STOCK PURCHASE WARRANT GT Biopharma, Inc.
Security Agreement • August 14th, 2026 • GT Biopharma, Inc. • Pharmaceutical preparations • New York

THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, PDPC Advisors Inc. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”), to subscribe for and purchase from GT Biopharma, Inc., a Delaware corporation (the “Company”), up to 400,000 shares of common stock, par value $0.001 per share (the “Common Stock”), of the Company (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SERIES B COMMON STOCK PURCHASE WARRANT BIOAFFINITY TECHNOLOGIES, INC.
Security Agreement • August 14th, 2026 • bioAffinity Technologies, Inc. • Services-commercial physical & biological research

THIS SERIES B COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the fifth anniversary of the Issue Date, provided that, if such date is not a Trading Day, the immediately following Trading Day (the “Termination Date”) but not thereafter, to subscribe for and purchase from bioAffinity Technologies, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SERIES A COMMON STOCK PURCHASE WARRANT BIOAFFINITY TECHNOLOGIES, INC.
Security Agreement • August 14th, 2026 • bioAffinity Technologies, Inc. • Services-commercial physical & biological research

THIS SERIES A COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the fifth anniversary of the Issue Date, provided that, if such date is not a Trading Day, the immediately following Trading Day (the “Termination Date”) but not thereafter, to subscribe for and purchase from bioAffinity Technologies, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SERIES A COMMON STOCK PURCHASE WARRANT CYABRA, INC.
Security Agreement • July 10th, 2026 • Cyabra, Inc. • Services-prepackaged software

THIS SERIES A COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [●] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (as defined below) (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the date that is the five (5) year anniversary of the Stockholder Approval Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Cyabra, Inc., a Delaware corporation (the “Company”), up to [•] shares of common stock, par value $0.0001 per share, of the Company (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SERIES B COMMON STOCK PURCHASE WARRANT CYABRA, INC.
Security Agreement • July 10th, 2026 • Cyabra, Inc. • Services-prepackaged software

THIS SERIES B COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [●] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (as defined below) (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the date that is the twelve (12) month anniversary of the Stockholder Approval Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Cyabra, Inc., a Delaware corporation (the “Company”), up to [●] shares of common stock, par value $0.0001 per share, of the Company (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

PRE-FUNDED COMMON STOCK PURCHASE WARRANT CYABRA, INC.
Security Agreement • July 10th, 2026 • Cyabra, Inc. • Services-prepackaged software

THIS PRE-FUNDED COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”), to subscribe for and purchase from Cyabra, Inc., a Delaware corporation (the “Company”), up to ______ shares of common stock, par value $0.0001 per share, of the Company (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”) . The purchase price of one shares of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).